Pharmaceutical industry market in France

compound, sodium, alzheimer, analgesic, analgesics, antacids, antidepressant, antidepressants, antivirals, arthritis, asthma, beds, breast cancer, cancer, cardiovascular diseases, central nervous system, chemotherapy, clinical trials, cns, cox 2 inhibitor, dentists, dermatology, generics, health expenditure, health insurance, healthcare, hospital, hospitals, hypertension, ingredients, lung cancer, mineral supplements, monoclonal antibody, neurology, oncology, osteoporosis, otc, otc pharmaceuticals, parkinson, pharmaceutical, pharmaceutical industry, pharmaceuticals, prostate cancer, santé, surgical, therapeutic classes, vaccine, vaccines, vitamin, vitamins,

world pharmaceutical markets september 2002 key facts population 2001 59 2 million gdp 2000 us 1 294 billion per capita 21 975 health expenditure 123 090 as of 9 5 hospital beds 000 pop 1999 8 3 doctors 23 382 wpm espicom business intelligence lincoln house city fields park way chichester west sussex po20 2fs united kingdom tel 44 0 1243 533322 fax 533418 http www com this page left intentionally blank western europe france i introduction background geographic political economic by region march census status 4 demographic indicators 1990 causes death deaths sex and principal cause 1998 6 7 morbidity cardiovascular diseases cancer respiratory disorders musucloskeletal neurological mental disorder renal disease 10 hiv aids hepatitis c hearing impairment 11 chronic